As of 2025-03-21, the Relative Valuation of Constellation Pharmaceuticals Inc (CNST) is (79.22) USD. This relative valuation is based on P/E multiples. With the latest stock price at 33.99 USD, the upside of Constellation Pharmaceuticals Inc based on Relative Valuation is -333.1%.
The range of the Relative Valuation is (62.97) - (90.45) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 21.4x - 36.4x | 28.9x |
| Forward P/E multiples | 19.2x - 30.7x | 25.0x |
| Fair Price | (62.97) - (90.45) | (79.22) |
| Upside | -285.2% - -366.1% | -333.1% |
| Date | P/E |